344 related articles for article (PubMed ID: 1658143)
1. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
[TBL] [Abstract][Full Text] [Related]
2. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
5. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
Moreno J; Adorini L; Hämmerling GJ
J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
7. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
8. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
Brooks AG; McCluskey J
J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
10. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
11. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
13. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
Rosloniec EF; Gay D; Freed JH
J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
[TBL] [Abstract][Full Text] [Related]
14. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules.
Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C
Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491
[TBL] [Abstract][Full Text] [Related]
15. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.
Nadimi F; Moreno J; Momburg F; Heuser A; Fuchs S; Adorini L; Hämmerling GJ
Eur J Immunol; 1991 May; 21(5):1255-63. PubMed ID: 2037011
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
[TBL] [Abstract][Full Text] [Related]
18. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.
Bikoff EK
J Immunol; 1992 Jul; 149(1):1-8. PubMed ID: 1318896
[TBL] [Abstract][Full Text] [Related]
19. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.
Bonifaz LC; Arzate S; Moreno J
Eur J Immunol; 1999 Jan; 29(1):119-31. PubMed ID: 9933093
[TBL] [Abstract][Full Text] [Related]
20. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
